Effects of losartan and amlodipine on urinary albumin excretion and ambulatory blood pressure in hypertensive type 2 diabetic patients with overt nephropathy

Diabetes Care

Volumn 28, Issue 8, 2005, Pages 1862-1868

  Yasuda, Gen ^a   Ando, Daisaku ^a   Hirawa, Nobuhito ^a   Umemura, Satoshi ^a   Tochikubo, Osamu ^a  

^a YOKOHAMA CITY UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; AMLODIPINE; ANTIHYPERTENSIVE AGENT; GLIBENCLAMIDE; GLICLAZIDE; INSULIN; LOSARTAN; TOLBUTAMIDE;

ADULT; AGED; ARTICLE; AUTONOMIC NERVOUS SYSTEM; BLOOD PRESSURE MONITORING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETIC NEPHROPATHY; EVALUATION; FEMALE; HEART RATE; HUMAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OPEN STUDY; PROSPECTIVE STUDY; PROTEINURIA; RANDOMIZED CONTROLLED TRIAL; SPECTRAL SENSITIVITY; SYSTOLIC BLOOD PRESSURE; URINARY EXCRETION;

ADULT; ALBUMINURIA; AMLODIPINE; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; BLOOD PRESSURE MONITORING, AMBULATORY; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; FEMALE; HEART RATE; HUMANS; HYPERTENSION; LOSARTAN; MALE; MIDDLE AGED;

EID: 23044453625     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.28.8.1862     Document Type: Article

References (28)

1. Lurbe A, Redón J, Pascual JM, Tacons J, Alvarez V, Batlle DC: Altered blood pressure during sleep in normotensive subjects with type 1 diabetes. Hypertension 21: 227-235, 1993
2. van Ittersum FJ, Spek JJ, Praet IJA, Lambert J, IJzerman RG, Fischer HRA, Nikkels RE, Van Bortel LMAB, Donker AJM, Stehouwer CDA: Ambulatory blood pressures and autonomic nervous function in normoalbuminuric type I diabetic patients. Nephrol Dial Transplant 13:326-332, 1998
3. Winocour PH, Dhar H, Anderson DC: The relationship between autonomic neuropathy and urinary sodium and albumin excretion in insulin-treated diabetics. Diabet Med 3:436-440, 1986
4. Equiluz-Bruck S, Schnack C, Kopp HP, Schernthaner G: Nondipping of nocturnal blood pressure is related to urinary albumin excretion rate in patients with type 2 diabetes mellitus. Am J Hypertens 9:1139-1143, 1996
5. Tarnow L, Hansen BV, Rossing P, Parving HH, Jensen C: Long-term renoprotective effect of nisoldipine and lisinopril in type 1 diabetic patients with diabetic nephropathy. Diabetes Care 23:1725-1730, 2000
6. Andersen S, Jacobsen P, Tarnow L, Rossing P, Juhl TR, Parving HH: Time course of the antiproteinuric and antihypertensive effect of losartan in diabetic nephropathy. Nephrol Dial Transplant 18:293-297, 2003
7. Rossing K, Hovind P, Christensen PK, Hansen HP, Andersen S, Parving HH: Comparative effects of irbesartan on ambulatory and office blood pressure. Diabetes Care 26:569-574, 2003
8. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL, Jones DW, Materson BJ, Oparil S, Wright JT, Roccella EJ: Seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure. Hypertension 42:1206-1252, 2003
9. Tochikubo O, Ikeda A, Miyajima E, Ishii M: Effects of insufficient sleep on blood pressure monitored by a new multibio-medical recorder. Hypertension 27:1318-1324, 1996
10. Bauduceau B, Genès N, Chamontin B, Vaur L, Renault M, Etienne S, Marre M: Ambulatory blood pressure and urinary albumin excretion in diabetic (non-insulin-dependent and insulin-dependent) hypertensive patients. Am J Hypertens 11: 1065-1073, 1998
11. Yasuda G, Hasegawa K, Kuji T, Ogawa N, Shimura G, Umemura S, Tochikubo O: Perindopril effects on ambulatory blood pressure: relation to sympathetic nervous activity in subjects with diabetic nephropathy. Am J Hypertens 17:14-20, 2004
12. Epstein M, Sowers JR: Diabetes mellitus and hypertension. Hypertension 19:403-418, 1992
13. Agardh CD, Garcia-Puig J, Charbonnel B, Angelkort B, Barnett AH: Greater reduction of urinary albumin excretion in hypertensive type 11 diabetic patients with incipient nephropathy by lisinopril than by nifedipme. J Hum Hypertens 10:185-192, 1996
14. Benhamou PY, Pitiot M, Halimi S, Siehe JP, De Gaudemaris R, Bachelot I, Boizel R, Mallion JM: Early disturbances of ambulatory blood pressure load in normotensive type 1 diabetic patients with microalbuminuria. Diabetes Care 15:1614-1619, 1992
15. Schmitz A, Pedersen MM, Hansen KW: Blood pressure by 24 h ambulatory recordings in type 2 (non-insulin dependent) diabetics: relationship to urinary albumin excretion. Diabetes Metab 17: 301-307, 1991
16. Mitchell TH, Nolan B, Henry M, Cronin C, Baker H, Greely G: Microalbuminuria in patients with non-insulin-dependent diabetes mellitus relates to nocturnal systolic blood pressure. Am J Med 102:531-535, 1997
17. Lacourcière Y, Bélanger A, Godin C, Hallé JP, Ross S, Wright N, Marion J: Long-term comparison of losartan and enalapril on kidney function in hypertensive type 2 diabetics with early nephropathy. Kidney Int 58:762-769, 2000
18. Houlihan CA, Casley DJ, Allen TJ, Cooper ME, Baxter AL, Jerums G, Panangiotopoulos S: A low-sodium diet potentiates the effects of losartan in type 2 diabetes. Diabetes Care 25:663-671, 2002
19. Rossing K, Carstensen B, Christensen PK, Parving HH, Hansen BV: Optimal dose of candesartan for renoprotection in type 2 diabetic patients with nephropathy. Diabetes Care 26:150-155, 2003
20. Weinrauch LA, Kennedy FP, Gleason RE, Keough J, D'Elia JA: Relationship between autonomic function and progression of renal disease in diabetic proteinuria. Am J Hypertens 11:302-308, 1998
21. Velussi M, Brocco E, Frigato F, Zolli M, Muollo B, Maioli M, Carraro A, Tonolo G, Fresu P, Cernigoi AM, Fioretto P, Nasadini R: Effects of cilazapril and amlodipine on kidney function in hypertensive NIDDM patients. Diabetes 45:216-222, 1996
22. Fogari R, Zoppi A, Malamani GD, Lusardi P, Destro M, Corradi L: Effects of amlodipine vs enalapril on microalbuminuria in hypertensive patients with type II diabetes. Clin Drug Invest 13:42-49, 1997
23. Smith AC, Toto R, Bakris GL: Differential effects of calcium channel blockers on size selectivity of proteinuria in diabetic glomerulopathy. Kidney Int 54:889-896, 1998
24. Praga M, Andrade CF, Luño J, Arias M, Poveda R, Mora J, Prat MV, Rivera F, Galceran JM, Ara JM, Aguirre R, Bernis C, Marin R, Campistol JM: Antiproteinuric efficacy of losartan in comparison with amlodipine in non-diabetic proteinuric renal diseases: a double-blind, randomized clinical trial. Nephrol Dial Transplant 18:1806-1813, 2003
25. Remuzzi G, Bertani T: Pathophysiology of progressive nephropathies. N Engl J Med 339:1448-1456, 1998
26. Anderson S, Rennke HG, Brenner BM: Nifedipine versus fosinopril in uninephrectomized diabetic rats. Kidney Int 41:891-897, 1992
27. Perico N, Amuchastegui SC, Colosio V, Sqnzogni G, Bertani T, Remuzzi G: Evidence that an angiotensin-converting enzyme inhibitor has a different effect on glomerular injury according to the different phase of the disease at which the treatment is started. J Am Soc Nephrol 5:1139-1146, 1994
28. Schmitz PG, O'Donnell MP, Kasiske BL, Katz SA, Keane WF: Renal injury in obese Zucker rats: glomerular hemodynamic alterations and effects of enalapril. Am J Physiol 263:F496-F502, 1992